Barely a week after mass firings at the Food and Drug Administration (FDA), some probationary staffers overseeing medical device approvals were unexpectedly reinstated over the weekend. The move follows intense backlash from the medical device industry, which pays hundreds of millions in fees to fund the FDA’s device review program. …
Read More »